Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00774215 · ClinicalTrials.gov registry record
Evaluation of the Avaulta Procedure for the Correction of Pelvic Organ Prolapse - Results at 1 Year
A clinical trial, sponsored by Atlantic Health System.
- Completed
- Registry status
- 103
- Enrollment target
NCT00774215: Completed study, sponsored by Atlantic Health System.
NCT00774215 is a clinical trial that has completed, run by Atlantic Health System. The registered enrollment target is 103 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00774215 has completed, sponsored by Atlantic Health System.
- COMPLETED
- Registry status
- 103 participants
- Enrollment target
Study Summary
This study is a 1 year review of all patients who had surgery to correct pelvic organ prolapse (i.e. cystocele, rectocele, enterocele) using the Avaulta synthetic mesh kit.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 103 participants |
| Start Date | 2007-10 |
| Est. Completion | 2009-04 |
What the finished NCT00774215 record still lists
NCT00774215 is an observational study that tracks outcomes without assigning an intervention. The registered 103 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT00774215 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00774215 about?
NCT00774215 is a clinical study titled "Evaluation of the Avaulta Procedure for the Correction of Pelvic Organ Prolapse - Results at 1 Year". This study is a 1 year review of all patients who had surgery to correct pelvic organ prolapse (i.e. cystocele, rectocele, enterocele) using the Avaulta synthetic mesh kit.
What is the current status of trial NCT00774215?
This trial is currently completed. The enrollment target is 103 participants. The study started on 2007-10. Estimated completion is 2009-04.
Who is sponsoring clinical trial NCT00774215?
This trial is sponsored by Atlantic Health System, which has 43 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04690348 · 103 participants · Phase 2
Intracavitary Carrier-embedded Cs131 Brachytherapy for Recurrent Brain Metastases: a Randomized Phase II Study
- NCT05282277 · 103 participants · Phase 4
Examining the Effects of Estradiol on Neural and Molecular Response to Reward
- NCT05566769 · 103 participants · NA
Performance and Safety of a Digital Tool for Unsupervised Self-assessment of NMOSD
- NCT05834478 · 103 participants · Phase 3
Non-invasive Vagal Nerve Stimulation in Opioid Use Disorders UH3
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia